Medical Affairs and Evidence Generation Asset Lead – Executive Director

argenx

21d • $325,600 - $447,700 • Remote

About The Position

The Medical Affairs and Evidence Generation (MA&EG) Asset Lead provides expert medical insights to inform indication selection, target product profile development, clinical development plans, and pre-launch and commercialization strategies. The role works with global cross-functional partners in science, clinical development, medical affairs and evidence generation, and commercial. In a “player coach” capacity, the lead is responsible for Integrated Evidence Generation Plans and other MA&EG activities, working with the broader MA&EG community supporting the asset. As the molecule progresses through its lifecycle, the individual will also hire, coach, and develop MA&EG indication leads.

The position represents the totality of MA&EG activities, insights, and deliverables on the argenx Asset Strategy Team and related cross-functional teams, providing strategic insights to maximize patient benefit. The lead also serves on the MA&EG Leadership Team and contributes to developing MA&EG at argenx.

This role is the MA&EG Strategy Lead for FB-102, a molecule acquired through Forte Biosciences. FB-102 is a first-in-class anti-CD122 monoclonal antibody designed to selectively modulate pathogenic T-cell and NK-cell activity driving autoimmune disease. Development efforts are ongoing in celiac disease, vitiligo, and alopecia areata.

The position is US-based, with remote work permitted. Travel of 30–40% may be needed, domestically and globally, and the role may require some time in argenx offices.

Requirements

• Advanced degree in a scientific specialty: MD, PhD, PharmD, or equivalent.
• 15 years of gastroenterology clinical practice, gastroenterology research, and/or gastroenterology biopharmaceutical industry experience.
• Ability to develop and maintain strong knowledge of complex disease areas, treatments, and clinical development plans.
• Ability to evaluate and interpret medical and scientific literature and the evolving treatment landscape to develop effective medical affairs strategies, with a track record of meeting or exceeding objectives.
• Excellent written and oral communication and interpersonal skills, including the ability to engage and influence diverse stakeholders and prepare, adapt, and deliver presentations on complex data.
• Ability to work in a complex, fast-moving, matrixed environment and lead teams through ambiguity, manage competing demands, prioritize, balance short- and long-term goals, and adapt to change.
• Ability to collaborate across functions and geographies and seek input from multiple stakeholders.
• Ability to balance team and individual responsibilities, give and receive feedback, contribute to a positive team environment, coach and develop people, and empower others.
• Strong problem-solving skills and a proactive, solution-oriented mindset, including the ability to develop innovative options.
• Detailed understanding of regulations and practices related to industry interactions with healthcare professionals and product access.
• Ability to travel 30–40% as needed, domestically and globally, and spend some time in argenx offices.

Nice To Haves

• At least 5 years of medical affairs industry experience is strongly preferred.
• Experience designing, conducting, and interpreting clinical trials.
• Knowledge of drug development and an existing expert network.
• Strong interpersonal skills and experience working as a team player in fast-paced, complex matrix environments and cross-functional teams.

Responsibilities

• Serve as the MA&EG lead on the FB-102 Asset Strategy Team, providing strategic guidance informed by regional and country MA&EG teams to guide development and lifecycle management.
• Identify potential new indications based on disease biology and mechanism to maximize patient outcomes and access.
• Work with FB-102 Science, Clinical Development, MA&EG, and Commercial teams on lifecycle deliverables from development through commercialization.
• Provide input into clinical trial protocols and study site selection, and partner with clinical study teams to troubleshoot study issues.
• Develop and execute Integrated Evidence Generation Plans throughout the product lifecycle.
• Lead the FB-102 MA&EG community and collaborate on medical strategies, including scientific communications and publications, advisory boards, medical information, congress activities, medical field content, and data generation.
• Regularly communicate the asset’s development strategy and plans to the MA&EG community.
• Hire and manage indication leads as the molecule advances in development.
• Co-create and drive MA&EG strategies as a member of the MA&EG Leadership Team, aligned with argenx Vision 2030 and its goals for investment across indications, molecules, and patient impact.
• Foster an inclusive, collaborative, flexible team environment that supports innovation and empowers people to do their best work.
• Ensure medical affairs activities meet high standards and comply with applicable pharmaceutical regulations and argenx policies and procedures.

Benefits

• Retirement savings plans.
• Health benefits.
• Other benefits subject to the terms of applicable plans and program guidelines.
• Eligibility to participate in short-term and long-term incentive programs, subject to plan terms and applicable policies.

What This Job Offers

• Job Type: Full-time
• Career Level: Executive
• Education Level: Ph.D. or professional degree